You just read:

Eisai Announces FDA Acceptance of Supplemental New Drug Application for Antiepileptic Drug Perampanel as Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures

News provided by

Eisai Inc.

Oct 20, 2014, 08:30 ET